KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by KalVista Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for KalVista Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pereira Brian JG | Director | – | Jun 11, 2026 | 2 |
| Unkart Edward W | Director | – | Jun 11, 2026 | 2 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 0 | Jun 11, 2026 | 14 |
| Reid Laurence | Director | – | Jun 11, 2026 | 1 |
| Stuart Nancy | Director | – | Jun 11, 2026 | 2 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | 0 | Jun 11, 2026 | 10 |
| Fairey William | Director | – | Jun 11, 2026 | 2 |
| Piekos Brian | Chief Financial Officer | 0 | Jun 11, 2026 | 6 |
| Sweeny Nicole | Chief Commercial Officer | 0 | Jun 11, 2026 | 7 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | 0 | Jun 11, 2026 | 10 |
| Sensenig Bethany | Director | – | Jun 11, 2026 | 2 |
| Treanor Patrick | Director | – | Jun 11, 2026 | 2 |
| Arif Bilal | Chief Operations Officer | – | Jun 11, 2026 | 3 |
| Koh Bong Y | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Shah Nimish P | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Management III, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Co-Investment Holdings III, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Management EG, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 72,858 | May 21, 2024 | 0 |
| Crockett Thomas Andrew | CEO | 211,203 | Feb 21, 2024 | 0 |
| Cha Albert | Director | 0 | Sep 28, 2023 | 0 |
| Smith Michael David | Senior VP, Development | – | May 19, 2022 | 0 |
| Edwards Martin | Director | – | Oct 4, 2021 | 0 |
| Soland Daniel B | Director | – | Oct 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 (view filing) | May 27 | 2 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −33.8K | $26.78 | −$905.2K | −12.8%229.9K after | |
| May 27, 2026 (view filing) | May 26 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.24K | $26.78 | −$60.0K | −1.5%150.3K after | |
| May 27, 2026 (view filing) | May 26 | 1 day | Sweeny NicoleChief Commercial Officer | SSale | −1.49K | $26.78 | −$39.9K | −2.4%59.3K after | |
| May 27, 2026 (view filing) | May 26 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.97K | $26.78 | −$52.6K | −0.8%229.9K after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.69K | $26.78 | −$71.9K | −1.8%147.5K after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Sweeny NicoleChief Commercial Officer | SSale | −1.86K | $26.78 | −$49.8K | −3.2%55.8K after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Piekos BrianChief Financial Officer | SSale | −1.49K | $26.78 | −$39.9K | −6.4%21.7K after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.36K | $26.78 | −$63.1K | −1.0%228.8K after | |
| May 26, 2026 (view filing) | May 22 | 4 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −10.9K | $26.78 | −$292.6K | −2.2%480.0K after | |
| May 19, 2026 (view filing) | May 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −1.03K | $26.76 | −$27.6K | −0.7%143.9K after | |
| May 19, 2026 (view filing) | May 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.11K | $26.76 | −$29.7K | −0.5%227.4K after | |
| May 19, 2026 (view filing) | May 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −1.13K | $26.76 | −$30.2K | −0.2%467.7K after | |
| May 13, 2026 (view filing) | May 12 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −3.32K | $26.71 | −$88.7K | −0.7%466.4K after | |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.69K | $20.22 | −$54.3K | −1.8%142.5K after | |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Sweeny NicoleChief Commercial Officer | SSale | −1.86K | $20.22 | −$37.6K | −3.5%51.4K after | |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Piekos BrianChief Financial Officer | SSale | −1.86K | $20.22 | −$37.6K | −9.3%18.1K after | |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −9.55K | $20.22 | −$193.1K | −2.0%462.6K after | |
| Mar 27, 2026 (view filing)5:50 PM ET | Mar 25-26 | 2 days | Koh Bong Y and 6 others10% Owner | SSale | −214.6K | $17.20 | −$3.69M | −4.0%5.09M after | 5 lots |
| Mar 10, 2026 (view filing) | Mar 9 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −6.69K | $16.08 | −$107.6K | −1.5%451.8K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −5.35K | $15.57 | −$83.4K | −3.7%139.0K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Sweeny NicoleChief Commercial Officer | SSale | −3.98K | $15.57 | −$61.9K | −7.8%47.0K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Piekos BrianChief Financial Officer | SSale | −1.77K | $15.57 | −$27.5K | −11.4%13.8K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −4.35K | $15.57 | −$67.7K | −1.9%226.7K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −10.0K | $15.57 | −$156.2K | −2.2%442.9K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −1.16K | $15.00 | −$17.4K | −0.9%133.1K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.11K | $15.00 | −$16.6K | −0.5%224.2K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −1.04K | $15.00 | −$15.6K | −0.2%429.7K after | |
| Feb 13, 2026 (view filing) | Feb 12 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −3.35K | $15.70 | −$52.7K | −0.8%428.3K after | |
| Dec 9, 2025 (view filing) | Dec 8 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.29K | $16.51 | −$120.4K | −1.7%424.5K after | |
| Dec 4, 2025 (view filing) | Nov 24 | 10 daysLate | Sweeny NicoleChief Commercial Officer | SSale | −3.81K | $13.45 | −$51.3K | −8.8%39.7K after | |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −5.30K | $13.45 | −$71.2K | −3.9%131.8K after | |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Piekos BrianChief Financial Officer | SSale | −4.47K | $13.45 | −$60.1K | −29.8%10.5K after | |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −4.33K | $13.45 | −$58.3K | −1.9%223.5K after | |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −10.9K | $13.45 | −$147.1K | −2.6%416.2K after | |
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −3.08K | $14.48 | −$44.5K | −2.4%125.9K after | |
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.68K | $14.48 | −$38.8K | −2.0%133.6K after | |
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −4.47K | $14.48 | −$64.7K | −1.1%403.9K after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −3.33K | $11.55 | −$38.4K | −0.8%399.0K after | |
| Sep 9, 2025 (view filing) | Sep 8 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.29K | $15.84 | −$115.5K | −1.8%395.2K after | |
| Aug 26, 2025 (view filing) | Aug 25 | 1 day | Sweeny NicoleChief Commercial Officer | SSale | −1.48K | $13.42 | −$19.9K | −4.4%32.3K after | |
| Aug 26, 2025 (view filing) | Aug 25 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.95K | $13.42 | −$26.2K | −1.5%132.1K after | |
| Aug 26, 2025 (view filing) | Aug 25 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.34K | $13.42 | −$31.3K | −1.9%122.5K after | |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Sweeny NicoleChief Commercial Officer | SSale | −1.86K | $13.22 | −$24.6K | −6.1%28.8K after | |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.36K | $13.22 | −$31.2K | −1.8%130.9K after | |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −10.9K | $13.22 | −$144.6K | −2.8%386.9K after | |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.94K | $13.22 | −$38.9K | −2.4%119.8K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.65K | $13.19 | −$34.9K | −2.0%129.5K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.94K | $13.19 | −$38.8K | −2.5%116.5K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −4.41K | $13.19 | −$58.2K | −1.2%374.5K after | |
| Jul 10, 2025 (view filing) | Jul 9 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −33.0K | $15.69 | −$517.4K | −8.2%369.6K after |